Vidita Chopra1, Kim Harley2, Maureen Lahiff3, Brenda Eskenazi4. 1. Center for Environmental Research and Children's Health (CERCH), School of Public Health, University of California Berkeley, Berkeley, CA 94720, USA. Electronic address: choprav@obgyn.ucsf.edu. 2. Center for Environmental Research and Children's Health (CERCH), School of Public Health, University of California Berkeley, Berkeley, CA 94720, USA. 3. Division of Biostatistics, School of Public Health, University of California Berkeley, Berkeley, CA, USA. 4. Center for Environmental Research and Children's Health (CERCH), School of Public Health, University of California Berkeley, Berkeley, CA 94720, USA. Electronic address: eskenazi@berkeley.edu.
Abstract
OBJECTIVE: This study investigates the association between urinary phthalate metabolite levels and attention deficit disorder (ADD), learning disability (LD), and co-occurrence of ADD and LD in 6-15-year-old children. METHODS: We used cross-sectional data from the National Health and Nutrition Examination Survey (NHANES, 2001-2004). Phthalate metabolites with ≥75% detection in urine samples were examined. The study population comprised 1493 children with parent-reported information on ADD or LD diagnosis and phthalate concentrations in urine. Phthalate concentrations were creatinine-adjusted and log10-transformed for analysis. All models controlled for child sex, age, race, household income, blood lead, and maternal smoking during pregnancy. RESULTS: There were 112 ADD cases, 173 LD cases, and 56 ADD and LD cases in the sample. After adjusting for potential confounders, we found increased odds of ADD with increasing urinary concentration of di-2-ethylhexyl phthalates (OR: 2.1; 95% CI: 1.1, 3.9) and high molecular weight phthalates (OR: 2.7; 95% CI: 1.2, 6.1). In addition, dibutyl phthalates (OR: 3.3; 95% CI: 0.9, 12.7) and high molecular weight phthalates (OR: 3.7; 95% CI: 0.9, 14.8) were marginally associated with increased odds of co-occurring ADD and LD. We did not find associations for any phthalate and LD alone. We observed stronger associations between phthalates and ADD and both ADD and LD in girls than boys in some models. CONCLUSIONS: We found cross-sectional evidence that certain phthalates are associated with increased odds of ADD and both ADD and LD. Further investigations with longitudinal data are needed to confirm these results.
OBJECTIVE: This study investigates the association between urinary phthalate metabolite levels and attention deficit disorder (ADD), learning disability (LD), and co-occurrence of ADD and LD in 6-15-year-old children. METHODS: We used cross-sectional data from the National Health and Nutrition Examination Survey (NHANES, 2001-2004). Phthalate metabolites with ≥75% detection in urine samples were examined. The study population comprised 1493 children with parent-reported information on ADD or LD diagnosis and phthalate concentrations in urine. Phthalate concentrations were creatinine-adjusted and log10-transformed for analysis. All models controlled for child sex, age, race, household income, blood lead, and maternal smoking during pregnancy. RESULTS: There were 112 ADD cases, 173 LD cases, and 56 ADD and LD cases in the sample. After adjusting for potential confounders, we found increased odds of ADD with increasing urinary concentration of di-2-ethylhexyl phthalates (OR: 2.1; 95% CI: 1.1, 3.9) and high molecular weight phthalates (OR: 2.7; 95% CI: 1.2, 6.1). In addition, dibutyl phthalates (OR: 3.3; 95% CI: 0.9, 12.7) and high molecular weight phthalates (OR: 3.7; 95% CI: 0.9, 14.8) were marginally associated with increased odds of co-occurring ADD and LD. We did not find associations for any phthalate and LD alone. We observed stronger associations between phthalates and ADD and both ADD and LD in girls than boys in some models. CONCLUSIONS: We found cross-sectional evidence that certain phthalates are associated with increased odds of ADD and both ADD and LD. Further investigations with longitudinal data are needed to confirm these results.
Authors: Thomas J Spencer; Joseph Biederman; Bertha K Madras; Stephen V Faraone; Darin D Dougherty; Ali A Bonab; Alan J Fischman Journal: Biol Psychiatry Date: 2005-06-01 Impact factor: 13.382
Authors: F A Arcadi; C Costa; C Imperatore; A Marchese; A Rapisarda; M Salemi; G R Trimarchi; G Costa Journal: Food Chem Toxicol Date: 1998-11 Impact factor: 6.023
Authors: R J Kavlock; G P Daston; C DeRosa; P Fenner-Crisp; L E Gray; S Kaattari; G Lucier; M Luster; M J Mac; C Maczka; R Miller; J Moore; R Rolland; G Scott; D M Sheehan; T Sinks; H A Tilson Journal: Environ Health Perspect Date: 1996-08 Impact factor: 9.031
Authors: Alison B Singer; Mary S Wolff; Manori J Silva; Antonia M Calafat; Stephanie M Engel Journal: Neurotoxicology Date: 2017-08-09 Impact factor: 4.294
Authors: Muhammad Ali Surhio; Farah N Talpur; Shafi M Nizamani; Marvi Kanwal Talpur; Hassan Imran Afridi; Abid Ali Khaskheli; Shazia Bhurgri; Junaid Ali Surhio Journal: Environ Sci Pollut Res Int Date: 2017-06-25 Impact factor: 4.223
Authors: S Verstraete; I Vanhorebeek; A Covaci; F Güiza; G Malarvannan; P G Jorens; G Van den Berghe Journal: Intensive Care Med Date: 2015-12-14 Impact factor: 17.440
Authors: Deborah J Watkins; John D Meeker; Marcela Tamayo-Ortiz; Brisa N Sánchez; Lourdes Schnaas; Karen E Peterson; Martha María Téllez-Rojo Journal: Environ Res Date: 2021-02-25 Impact factor: 6.498